|
Patent landscape, scope, and claims summary: |
Patent 10,031,080: Claims and Landscape Analysis
United States Patent 10,031,080 (issued July 24, 2018) titled "Methods of Using Ketogenic Composition" claims a method for treating or preventing a disorder related to metabolic imbalance through administering a ketogenic formulation. This report offers an in-depth review of the patent's claims and its position within the broader patent landscape.
What Are the Core Claims of Patent 10,031,080?
The patent claims encompass methods involving administering a ketogenic composition comprising a specific ratio of macronutrients—primarily high fat, low carbohydrate, and adequate protein—to treat neurological, metabolic, or inflammatory disorders.
Key Claim Elements:
- Use of a ketogenic composition with a specified macronutrient ratio (fat: carbohydrate + protein).
- Treatment of disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, and other neurodegenerative or metabolic disorders.
- Method of administering the ketogenic composition, which can include dietary or supplement-based approaches.
Claim Scope:
- Independent Claims: Cover methods of treatment using a ketogenic diet or supplement characterized by particular macronutrient ratios.
- Dependent Claims: Specify additional features such as timing, dosage, or specific formulations.
Claim Critique:
The claims are broad in covering any method of treatment using the specified ketogenic ratios for numerous disorders. They lack narrower limitations on composition specifics or modes of administration, possibly making them susceptible to challenge under prior art.
Patent Landscape and Prior Art
Key Competitors and Related Patents:
- Numerous patents target ketogenic diet applications, especially for epilepsy (US Patents 6,924,234; 8,714,342).
- Recent filings focus on ketogenic formulations for neurodegenerative diseases (e.g., US Patent Application 20170217534 by Casiero et al.).
- Patents on specific formulations, such as ketone esters, ketone salts, and specialized delivery systems, are prominent.
Patent Filing Trends:
- Filing activity surged between 2014-2018, coinciding with increased research in ketogenic therapies.
- Major organizations involved include biotech firms, universities, and pharma companies.
Overlap with Industry Innovations:
- Claims mirror those in prior art related to ketogenic treatments for epilepsy, with emerging emphasis on broader neurological indications.
- The broad claims in 10,031,080 may overlap with existing patents covering dietary management or supplementary composition use.
Patentability Concerns:
- Prior art references describe similar methods and compositions.
- The broad scope possibly challenges novelty and inventive step, especially given prior disclosures on ketogenic therapy methods.
- The specific ratios and treatment claims need further narrowing to strengthen patent validity.
Critical Appraisal of the Claims
- The scope is extensive, covering any ketogenic composition fitting the ratio for multiple disorders.
- The application of the claims to a broad patient population increases vulnerability to prior art challenges.
- The patent's strength hinges on the novelty of specific compositions or administration methods not disclosed previously.
Limitations:
- Lack of detailed formulation specifics limits enforceability.
- The broad claims may face infringement challenges from existing diet-based or supplement-based patents.
Opportunities for Patent Prosecution:
- Narrow claims to specific formulations with unique delivery systems.
- Emphasize particular treatment regimens or novel macronutrient ratios.
- Focus on innovative compositions not previously disclosed.
Key Competitors and Subsequent Patents
| Patent Number |
Title |
Filing Year |
Focus Area |
Notable Features |
| US 8,714,342 |
Ketogenic Diet for Seizure Control |
2014 |
Epilepsy treatment |
Specific diet plans and formulations |
| US 20170217534 |
Composition for Neurodegenerative Disorders |
2017 |
Neurodegenerative disease therapy |
Novel compositions with ketone esters |
| US 9,962,711 |
Ketone Salt Formulations |
2015 |
Ketone salt compositions |
Delivery methods and formulations |
Note: Patent activity indicates diversified approaches, ranging from dietary protocols to chemical formulations, emphasizing the importance of precise claim scope.
Strategic Implications
- Prior art presents significant hurdles; claims need refinement.
- Focus on patenting unique delivery mechanisms, proprietary compositions, or specific patient treatment protocols.
- Continual monitoring of new filings, especially in personal nutrition and neurodegenerative therapy space, remains necessary.
Key Takeaways
- Patent 10,031,080 claims broad methods of using ketogenic compositions for various disorders, but faces challenges from prior art.
- The patent landscape is active, featuring a mix of diet-based, chemical, and device-oriented patents.
- To strengthen enforceability, future patent filings should refine claims toward specific, novel compositions or methods.
- Industry players should assess the scope of this patent in relation to emerging treatments and formulations to avoid infringement or to identify licensing opportunities.
FAQs
-
What makes Patent 10,031,080 unique compared to prior art?
Its specific macronutrient ratios and broad applicability to multiple disorders are emphasized but lack narrow inventive features.
-
Can the claims be challenged on the grounds of obviousness?
Yes, given existing patents on ketogenic diets for epilepsy and other conditions, the broad claims may be considered an obvious extension.
-
What types of formulations are most relevant to this patent?
Dietary plans, oral supplements, and modified macronutrient ratios are the primary focus.
-
How might this patent impact competitors?
It may restrict methods of administering ketogenic compositions broadly but could be circumvented by designing around narrower claims or new formulations.
-
What areas should patent applicants focus on for future filings?
Novel delivery systems, unique compositions, or specific treatment protocols that differ from existing art.
References
[1] United States Patent and Trademark Office. (2018). Patent No. 10,031,080. Methods of Using Ketogenic Composition.
[2] Casiero, D., et al. (2017). Composition for Neurodegenerative Disorders. US Patent Application 20170217534.
[3] Watanabe, M., et al. (2014). Ketogenic Diet for Seizure Control. US Patent 8,714,342.
[4] Koppel, S. J., et al. (2015). Ketone Salt Formulations. US Patent 9,962,711.
More… ↓
⤷ Start Trial
|
